At the same time, payer policies often require discontinuation of GLP-1 therapy when a patients BMI drops below a set threshold, inadvertently triggering a frustrating cycle of weight loss and regainthe so-called yo-yo effect. This not only impacts ongoing adherence and persistence but also undermines the long-term cost-effectiveness of these therapies for healthcare systems
Marie Liebmann, Department of Neurology with Institute of Translational Neurology, Germany Updates Copyright 2022 Zhong, Ran, Gao, Shi, Shi, Long, Zhou, Yang, Tang, Lin, He, Yu and Han
This provides a sustained signal that primes the pituitary for a prolonged period of GH release, deeply supporting long-term physiological regulation
While more research is needed to further understand NAION and Ozempic, the results are strong enough to warrant action and attention
10) Practical dosing guardrails (for adults) Typical ceiling: 3,0004,000 mg/day total from all sources